Paul Burton, M.D., Ph.D., FRCP, is the Chief Medical Officer at Moderna. With over two decades of experience in the biopharmaceutical industry, he has played pivotal roles in drug discovery and development across various therapeutic areas. His tenure at Moderna has been marked by significant contributions to medical strategy and patient safety.
Who is the CMO of Moderna?
Paul Burton, M.D., Ph.D., FRCP, is a distinguished figure in the biopharmaceutical industry, currently serving as the Chief Medical Officer at Moderna. With a robust educational background that includes a Ph.D. in molecular and cellular biology and postgraduate training in cardiovascular surgery, Burton has amassed over two decades of experience. His career spans significant roles such as Chief Global Medical Affairs Officer at Johnson & Johnson and Global Development Leader at Amgen. At Moderna, he oversees global medical strategy, patient safety, and pharmacovigilance, contributing to advancements in various therapeutic areas, including oncology, cardiovascular diseases, and infectious diseases.
Work History
Paul Burton, M.D., Ph.D., FRCP, has an extensive work history in the biopharmaceutical industry. Here is a detailed list of his previous positions:
- Amgen - Chief Medical Officer (June 2023 - Present)
- Moderna - Chief Medical Officer (July 2021 - June 2023)
- The Janssen Pharmaceutical Companies of Johnson & Johnson - Chief Global Medical Affairs Officer (March 2020 - June 2023)
- The Janssen Pharmaceutical Companies of Johnson & Johnson - Vice President, Cardiovascular and Metabolism Medical Affairs (January 2014 - January 2020)
- The Janssen Pharmaceutical Companies of Johnson & Johnson - Vice President Global Clinical Operations Head for the Americas (January 2012 - January 2014)
- The Janssen Pharmaceutical Companies of Johnson & Johnson - Vice President, Cardiovascular Franchise Medical Leader (January 2011 - January 2012)
- Johnson & Johnson - Senior Medical Director (November 2006 - February 2011)
- The Janssen Pharmaceutical Companies of Johnson & Johnson - Medical Director (January 2005 - January 2006)
- MILLENNIUM PHARMACEUTICALS, INC. - Medical Director (January 2005 - January 2005)
- Amgen - Global Development Leader (January 2002 - January 2005)
- Immunex - Staff Scientist (January 2001 - January 2002)
Education History
Paul Burton, M.D., Ph.D., FRCP, has an impressive educational background that spans several prestigious institutions. He began his academic journey at King's College London, where he earned a BSc in Physiology from 1987 to 1990. He then pursued a Doctor of Medicine (MD) at the United Medical and Dental Schools of Guys and St. Thomas' Hospitals, London University, completing it between 1990 and 1995. Following this, Burton obtained a Doctor of Philosophy (PhD) from Imperial College London, studying from 1996 to 1998. He furthered his medical qualifications by earning the MRCS from the Royal College of Surgeons of Edinburgh, UK, from 1998 to 2001. Most recently, he was awarded the FRCP by the Royal College of Physicians in 2023, underscoring his continued commitment to medical excellence.
When did Paul Burton MD PhD FRCP join Moderna?
In July 2021, Paul Burton, M.D., Ph.D., FRCP, joined Moderna as the Chief Medical Officer. During his tenure, which lasted until June 2023, Burton was responsible for overseeing global medical strategy, patient safety, and pharmacovigilance. His role at Moderna marked a significant period in his career, contributing to the company's advancements in various therapeutic areas. Burton's time at Moderna spanned approximately two years, during which he played a crucial role in the company's medical and strategic initiatives.